Treatment of non-life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 2, 2009, Pages 201-207

  Drekonja, Dimitri M ^a,b   Traynor, Laura M ^c   DeCarolis, Douglas D ^a,c   Crossley, Kent B ^a,b   Johnson, James R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antimicrobial resistance; Antimicrobial therapy; Methicillin resistant Staphylococcus aureus; Tetracycline; Trimethoprim sulfamethoxazole

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; LEVOFLOXACIN; MINOCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE INFECTION; CREATININE BLOOD LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYOSITIS; PRIORITY JOURNAL; RASH; SIDE EFFECT; SKIN INFECTION; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MINOCYCLINE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 58149481479     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.10.001     Document Type: Article

References (22)

1. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb. Mortal. Wkly. Rep. 52 (2003) 793-795
2. Al-Rawahi G.N., Reynolds S., Porter S.D., Forrester L., Kishi L., Chong T., Bowie W.R., and Doyle P.W. Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian Tertiary Care Hospital. J. Emerg. Med. (2008) In press, corrected proof
3. Cenizal M.J., Skiest D., Luber S., Bedimo R., Davis P., Fox P., Delaney K., and Hardy R.D. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51 (2007) 2628-2630
4. Chambers H. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. Dis. 7 (2001) 178-182
5. Fridkin S.K., Hageman J.C., Morrison M., Sanza L.T., Como-Sabetti K., Jernigan J.A., Harriman K., Harrison L.H., Lynfield R., and Farley M.M. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352 (2005) 1436-1444
6. Honda T., Hayasaka M., Hachiya T., Kubo K., Katsuyama T., and Nagata A. Two cases of severe bronchiectasis successfully treated with a prolonged course of trimethoprim/sulfamethoxazole. Intern. Med. 35 (1996) 979-983
7. Kilic A., Li H., Stratton C.W., and Tang Y.W. Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee. J. Clin. Microbiol. 44 (2006) 4436-4440
8. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., and Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144 (2006) 309-317
9. Klevens R.M., Edwards J.R., Tenover F.C., McDonald L.C., Horan T., and Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin. Infect. Dis. 42 (2006) 389-391
10. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol. 20 (1999) 250-278 quiz 279--80
11. Markowitz N., Quinn E.L., and Saravolatz L.D. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann. Intern. Med. 117 (1992) 390-398
12. Martinez-Aguilar G., Hammerman W.A., Mason Jr. E.O., and Kaplan S.L. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 22 (2003) 593-598
13. Micek S.T. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 45 Suppl 3 (2007) S184-S190
14. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., and Talan D.A. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355 (2006) 666-674
15. Proctor R.A. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46 (2008) 584-593
16. Ruhe J.J., and Menon A. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51 (2007) 3298-3303
17. Ruhe J.J., Monson T., Bradsher R.W., and Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin. Infect. Dis. 40 (2005) 1429-1434
18. Ruhe J.J., Smith N., Bradsher R.W., and Menon A. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin. Infect. Dis. 44 (2007) 777-784
19. Stein A., Bataille J.F., Drancourt M., Curvale G., Argenson J.N., Groulier P., and Raoult D. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob. Agents Chemother. 42 (1998) 3086-3091
20. Stevens D.L., Bisno A.L., Chambers H.F., Everett E.D., Dellinger P., Goldstein E.J., Gorbach S.L., Hirschmann J.V., Kaplan E.L., Montoya J.G., and Wade J.C. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 41 (2005) 1373-1406
21. Tsuji B.T., Rybak M.J., Cheung C.M., Amjad M., and Kaatz G.W. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn. Microbiol. Infect. Dis. 58 (2007) 41-47
22. Yuk J.H., Dignani M.C., Harris R.L., Bradshaw M.W., and Williams Jr. T.W. Minocycline as an alternative antistaphylococcal agent. Rev. Infect. Dis. 13 (1991) 1023-1024